The Enterprise Value as of June 2026 (TTM) for Bio-Works Technologies AB (publ) (BIOWKS.ST) is 240.21M

According to Bio-Works Technologies AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 240.21M. This represents a change of 17.78% compared to the average of 203.94M of the last 4 quarters.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Historical Enterprise Value (quarterly & annually)

How has BIOWKS.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Bio-Works Technologies AB (publ) over the last ten years is 272.82M. The current 240.21M Enterprise Value has changed 8.70% with respect to the historical average. Over the past ten years (40 quarters), BIOWKS.ST's Enterprise Value was at its highest in in the December 2021 quarter at 777.17M. The Enterprise Value was at its lowest in in the September 2024 quarter at -4892009.46.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bio-Works Technologies AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Works Technologies AB (publ) (BIOWKS.ST) Average Enterprise Value

How has BIOWKS.ST Enterprise Value performed in the past?

The current Enterprise Value of Bio-Works Technologies AB (publ) (BIOWKS.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bio-Works Technologies AB (publ) (BIOWKS.ST) Enterprise Value vs. Peers

How is BIOWKS.ST’s Enterprise Value compared to its peers?

Bio-Works Technologies AB (publ)’s Enterprise Value is greater than Initiator Pharma A/S (122.30M), greater than IRLAB Therapeutics AB (publ) (83.31M), less than Lipum AB (publ) (302.84M), greater than Karolinska Development AB (publ) (-28917591.00), greater than Isofol Medical AB (publ) (160.59M), greater than Annexin Pharmaceuticals AB (publ) (68.92M), greater than Alzinova AB (publ) (39.54M), greater than iZafe Group AB (publ) (160.75M), greater than SenzaGen AB (160.47M), greater than Clinical Laserthermia Systems AB (publ) (79.44M),

Build a custom stock screener for Bio-Works Technologies AB (publ) (BIOWKS.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Works Technologies AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Works Technologies AB (publ) (BIOWKS.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Works Technologies AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.